NCT01177631已完成不适用
Proteomic Analysis of Human Hepatocellular Carcinoma Associated With Portal Vein Thrombosis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 5
- 试验地点
- 2
- 主要终点
- Recurrence
研究概览
简要总结
This is a pilot study to evaluate the difference between the protein expression between hepatocellular carcinoma and tumor with vessel invasion in Asian patients with hepatocellular carcinoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Arm A: Hepatocellular carcinoma with vessel invasion:
- •hepatocellular carcionoma, pathologic diagnosed.
- •image documented vessel invasion, including portal vein thrombosis
- •eligible for surgical intervension.
- •Arm B: hepatocellular carcinoma without vessel invasion:
- •hepatocellular carcinoma, pathologic diagnosed or clinical diagnosed according to EASL criteria.
- •no vessel invasion on image.
- •Arm C: Healthy hepatitis carrier:
- •patients age >18 years old with hepatitis B or C
- •normal liver function.
排除标准
- 未提供
结局指标
主要结局
Recurrence
时间窗: one year
Evidence of clinically definite vascular invasion of hepatocellular carcinoma. Confirmed by operation. Compare the proteomic expression of tumor, non-tumor ans tumor tissue in vascular part.
次要结局
未报告次要终点
研究者
Meng-Tzu Weng
Physician
Far Eastern Memorial Hospital
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
Risk of Hepatocellular Carcinoma in Patient With Liver CirrhosisCarcinoma, HepatocellularNCT03083002University of Modena and Reggio Emilia250
招募中
不适用
Identification and Prognostic Value of Key Genes in Hepatocellular CarcinomaHepatocellular CarcinomaNCT05759858Second Affiliated Hospital, School of Medicine, Zhejiang University100
招募中
不适用
Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion TherapyHepatocellular CarcinomaNCT06382103Shanghai Zhongshan Hospital240
Unknown
不适用
Genetic Studies in Liver Cancer PatientsHepatocellular CarcinomaNCT00172640National Taiwan University Hospital40
招募中
Unknown
Evaluation of molecular biomarkers for hepatocellular carcinoma (HCC) therapyLiver CirrhosisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCancer - LiverLiver CancerHepatocellular CarcinomaACTRN12623000762651A/Prof Adam Testro150